Biotech Oral semaglutide 14 mg demonstrated superior reduction in risk of cardiovascular events in late-breaking SOUL trial presented at the American College of Cardiology March 30, 2025
Biotech FDA Approves Novel Treatment for Hemophilia A or B, with or without Factor Inhibitors March 29, 2025
Biotech ARTHEx Biotech to Participate in the 24th Annual Needham Virtual Healthcare Conference March 27, 2025
Biotech BioArctic’s partner Eisai presents sales simulation for Leqembi® at its annual press conference March 25, 2025
Biotech Clover Announces U.S. IND Clearance and Initiation of Revaccination Clinical Study for RSV Vaccine Candidate SCB-1019 March 24, 2025
Biotech Nektar Therapeutics to Participate in the H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference March 21, 2025
Search
Biotech
March 30, 2025
March 29, 2025
March 28, 2025
March 27, 2025
March 26, 2025
March 25, 2025
March 24, 2025
March 23, 2025
March 22, 2025
March 21, 2025
